Over-the-counter drug · ANDA
Polyethylene Glycol 3350 NDC 50844-772
Polyethylene glycol 3350 17 g/17g · Powder, For solution · Oral · L.N.K. International, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50844-772-01 | 50844077201 | 30 PACKET in 1 CARTON (50844-772-01) / 17 g in 1 PACKETMarketed from Sep 10, 2026 | |
| 50844-772-03 | 50844077203 | 10 PACKET in 1 CARTON (50844-772-03) / 17 g in 1 PACKETMarketed from Sep 10, 2026 | |
| 50844-772-09 | 50844077209 | 20 PACKET in 1 CARTON (50844-772-09) / 17 g in 1 PACKETMarketed from Sep 10, 2026 | |
| 50844-772-12 | 50844077212 | 100 PACKET in 1 CARTON (50844-772-12) / 17 g in 1 PACKETMarketed from Sep 10, 2026 | |
| 50844-772-43 | 50844077243 | 17 g in 1 PACKET (50844-772-43)Marketed from Sep 10, 2026 | |
| 50844-772-48 | 50844077248 | 14 PACKET in 1 CARTON (50844-772-48) / 17 g in 1 PACKETMarketed from Sep 10, 2026 | |
| 50844-772-49 | 50844077249 | 238 g in 1 BOTTLE, PLASTIC (50844-772-49)Marketed from Sep 10, 2026 | |
| 50844-772-90 | 50844077290 | 510 g in 1 BOTTLE, PLASTIC (50844-772-90)Marketed from Sep 10, 2026 | |
| 50844-772-92 | 50844077292 | 119 g in 1 BOTTLE, PLASTIC (50844-772-92)Marketed from Sep 10, 2026 | |
| 50844-772-93 | 50844077293 | 578 g in 1 BOTTLE, PLASTIC (50844-772-93)Marketed from Sep 10, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Polyethylene Glycol 3350
- Generic name (nonproprietary)
- polyethylene glycol 3350
- Active ingredients
- Polyethylene glycol 3350 — 17 g/17g
- Dosage form
- Powder, For solution
- Route
- Oral
- Labeler
- L.N.K. International, Inc.
- Product type
- Over-the-counter drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 217505
- Marketing start
- Listing expires
- Other FDA classes
- Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 50844-772_41972e0f-61cb-43d5-a74e-f10ee85dcfe8SPL ID 41972e0f-61cb-43d5-a74e-f10ee85dcfe8SPL set ID bbc11078-73f7-4d27-b0d3-4d4ae5dae240RxCUI 876193UNII G2M7P15E5PUPC 0350844772039
- Pharmacologic class
- Osmotic Laxative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450844077201followed by a unit qualifier and the quantityPackage 50844-0772-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Use relieves occasional constipation (irregularity) generally produces a bowel movement in 1 to 3 days
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 217505
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Peg3350polyethylene glycol 3350 | Polyethylene glycol 3350 17 g/17g | Powder, For solutionOral | Major Pharmaceuticals | 0904-7534 |